Q3 2021 Holdings
Filed 2021-11-15 | 61 holdings | $27.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aveanna Healthcare Holdings Inc(AVAH) | COM | 05356F105 | $11.2M | 1,397,272 | 40.5% |
| Centene Corp(CNC) | COM | 15135B101 | $11.2M | 179,232 | 40.4% |
| Cross Country Healthcare Inc(CCRN) | COM | 227483104 | $4.2M | 199,460 | 15.3% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $755.0K | 572,082 | 2.7% |
| Cigna Corp(CI) | COM | 125523100 | $27.7K | 138,224 | 0.1% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $22.8K | 2,914,127 | 0.1% |
| Spdr Gold Shares(GLD) | GOLD SHS | 78463V107 | $16.8K | 102,553 | 0.1% |
| Soliton Inc(SOLY) | COM | 834251100 | $16.8K | 824,803 | 0.1% |
| Universal Health Services Inc(UHS) | CL B | 913903100 | $14.0K | 101,051 | 0.1% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $13.7K | 56,409 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $11.8K | 224,719 | 0.0% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $10.9K | 59,146 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $9.4K | 125,000 | 0.0% |
| Herbalife Nutrition LTD(HLF) | COM SHS | G4412G101 | $9.2K | 216,012 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $8.7K | 43,797 | 0.0% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $7.0K | 141,423 | 0.0% |
| Renovacor Inc | COM | 75989E106 | $6.7K | 736,323 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $6.7K | 213,493 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $5.0K | 248,978 | 0.0% |
| Integer Holdings Corp(ITGR) | COM | 45826H109 | $4.9K | 54,891 | 0.0% |
| Healthequity Inc(HQY) | COM | 42226A107 | $4.8K | 73,458 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $4.6K | 25,500 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $4.6K | 65,500 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $4.3K | 228,318 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $4.3K | 804,597 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $4.2K | 660,813 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $4.0K | 900,677 | 0.0% |
| Spruce Biosciences Inc | COM | 85209E109 | $3.6K | 603,027 | 0.0% |
| Ayala Pharmaceuticals Inc | COM | 05465V108 | $3.6K | 318,599 | 0.0% |
| Aeglea BIO Therapeutics Inc(AGLEUSD) | COM | 00773J103 | $3.5K | 446,000 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $3.3K | 913,621 | 0.0% |
| Neubase Therapeutics Inc | COM | 64132K102 | $3.3K | 906,445 | 0.0% |
| Horizon Therapeutics PLC | SHS | G46188101 | $3.2K | 29,319 | 0.0% |
| Moleculin Biotech Inc | COM | 60855D200 | $3.1K | 1,040,529 | 0.0% |
| Radius Health Inc | COM NEW | 750469207 | $3.0K | 241,905 | 0.0% |
| Precision Biosciences Inc | COM | 74019P108 | $3.0K | 257,167 | 0.0% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $2.6K | 623,892 | 0.0% |
| Eucrates Biomedical Acquisition Corp. | UNIT 10/23/2027 | G3141W114 | $2.5K | 248,674 | 0.0% |
| Health Sciences Acquisitions Corp 2 | ORD SHS | G4411D109 | $2.5K | 250,000 | 0.0% |
| Aslan Pharmaceuticals LTD | ADS | 04522R101 | $2.3K | 1,270,758 | 0.0% |
| Cyclacel Pharmaceuticals Inc | COM | 23254L603 | $2.2K | 422,598 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $2.1K | 95,450 | 0.0% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $2.1K | 259,763 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $2.1K | 562,339 | 0.0% |
| Cortexyme Inc(QNCX)Put | COM | 22053A107 | $2.0K | 22,200 | 0.0% |
| Leap Therapeutics Inc | COM | 52187K101 | $1.8K | 440,000 | 0.0% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $1.7K | 102,049 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $1.6K | 90,000 | 0.0% |
| Evelo Biosciences IncPut | COM | 299734103 | $1.5K | 206,300 | 0.0% |
| Salarius Pharmaceuticals Inc | COM NEW | 79400X107 | $1.4K | 1,354,291 | 0.0% |